These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8917738)
41. Differences in immunoglobulin preparations and outcome of Kawasaki disease. Yavuz H; Ozel A J Pediatr; 1996 May; 128(5 Pt 1):719-20. PubMed ID: 8627453 [No Abstract] [Full Text] [Related]
42. A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin. Gordon DJ; Sloan SR; de Jong JL Am J Hematol; 2009 Nov; 84(11):771-2. PubMed ID: 19806664 [No Abstract] [Full Text] [Related]
43. Lambert-Eaton myasthenic syndrome: Epidemiology and therapeutic response in the national veterans affairs population. Abenroth DC; Smith AG; Greenlee JE; Austin SD; Clardy SL Muscle Nerve; 2017 Sep; 56(3):421-426. PubMed ID: 27997683 [TBL] [Abstract][Full Text] [Related]
45. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports. Schneider I; Kornhuber ME; Hanisch F J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033 [TBL] [Abstract][Full Text] [Related]
46. Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Rees JH J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):148-9. PubMed ID: 9489520 [No Abstract] [Full Text] [Related]
47. Marked pleural effusion after i.v. immunoglobulin therapy for Kawasaki disease. Koizumi K; Hoshiai M; Toda T; Nakane T; Sugita K Pediatr Int; 2018 Mar; 60(3):307-308. PubMed ID: 29480538 [No Abstract] [Full Text] [Related]
48. Intravenous gammaglobulin, 2: Pharmacology, clinical uses and mechanisms of action. Schiff RI Pediatr Allergy Immunol; 1994 Aug; 5(3):127-56. PubMed ID: 7951755 [No Abstract] [Full Text] [Related]
49. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy. Yoshida S; Sakurai Y; Takeda T; Fukuda K J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975 [No Abstract] [Full Text] [Related]
50. Kawasaki disease. Sundel RP Rheum Dis Clin North Am; 2015; 41(1):63-73, viii. PubMed ID: 25399940 [TBL] [Abstract][Full Text] [Related]
51. The safety of immune globulins. Tepper M; Gully P Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937 [No Abstract] [Full Text] [Related]
52. Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin. Vedanarayanan V; Subramony SH; Ray LI; Evans OB Pediatr Neurol; 1995 Nov; 13(4):336-9. PubMed ID: 8771171 [TBL] [Abstract][Full Text] [Related]
59. Treatment of a Jehovah's Witness with immune globulin: case of a child with Kawasaki syndrome. Roy-Bornstein C; Sagor LD; Roberts KB Pediatrics; 1994 Jul; 94(1):112-3. PubMed ID: 8008516 [No Abstract] [Full Text] [Related]